跳至主要内容
临床试验/NCT03928964
NCT03928964Unknown不适用

Pronostic Assessment of Mortality Among Locally Advanced or Metastatic Renal Cell Carcinoma Patients After First Line Treatment : Multicenter Prospective Cohort Study With Historic Medical Data

Centre Hospitalier Universitaire de Besancon8 个研究点 分布在 1 个国家目标入组 440 人开始时间: 2018年1月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
440
试验地点
8
主要终点
Overall survival after the first line of treatment

研究概览

简要总结

The hypothesis of this study are as follows:

  • Prognostic evaluation of patients based on an integrative model provides better assessment of overall survival, and thus improves setting of care goals.
  • In a routine care population, antitumour drugs may have a significant impact on overall survival through their targeted antitumor effect, but also through their toxicity profile and their impact on comorbidities.
  • The optimization of patient support (supportive care, drug tolerance monitoring) can have an impact on the prognosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Overall survival after the first line of treatment

时间窗: year 11

Time elapsed between initiation date for 2nd line treatment et the date of death, whatever the cause.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验